ROLIMUS 10 TABLETS

Form: Tablet

Pack Size: 10 Tablets

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹11434.50

Rolimus 10mg by Cipla (everolimus 10 mg, 10 tablets) is an mTOR inhibitor (targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for advanced hormone receptor-positive breast cancer (with exemestane), advanced kidney cancer, neuroendocrine tumours and tumours linked to tuberous sclerosis complex. Schedule H: dispense only against a valid prescription. Counselling point: mouth ulcers are common; new cough or breathlessness needs review (possible pneumonitis).

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.